Late-onset Alzheimer's disease, heating up and foxed by several proteins: Pathomolecular effects of the aging process

Felipe P. Perez, David Bose, Bryan Maloney, Kwangsik Nho, Kavita Shah, Debomoy Lahiri

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Late-onset Alzheimer's disease (LOAD) is the most common neurodegenerative disorder in older adults, affecting over 50% of those over age 85. Aging is the most important risk factor for the development of LOAD. Aging is associated with the decrease in the ability of cells to cope with cellular stress, especially protein aggregation. Here we describe how the process of aging affects pathways that control the processing and degradation of abnormal proteins including amyloid-β (Aβ). Genetic association studies in LOAD have successfully identified a large number of genetic variants involved in the development of the disease. However, there is a gap in understanding the interconnections between these pathomolecular events that prevent us from discovering therapeutic targets. We propose novel, pertinent links to elucidate how the biology of aging affects the sequence of events in the development of LOAD. Furthermore we analyze and synthesize the molecular-pathologic-clinical correlations of the aging process, involving the HSF1 and FOXO family pathways, Aβ metabolic pathway, and the different clinical stages of LOAD. Our new model postulates that the aging process would precede Aβ accumulation, and attenuation of HSF1 is an 'upstream' event in the cascade that results in excess Aβ and synaptic dysfunction, which may lead to cognitive impairment and/or trigger 'downstream' neurodegeneration and synaptic loss. Specific host factors, such as the activity of FOXO family pathways, would mediate the response to Aβ toxicity and the pace of progression toward the clinical manifestations of AD.

Original languageEnglish
Pages (from-to)1-17
Number of pages17
JournalJournal of Alzheimer's Disease
Volume40
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Heating
Alzheimer Disease
Proteins
Serum Amyloid A Protein
Aptitude
Genetic Association Studies
Heat-Shock Proteins
Metabolic Networks and Pathways
Neurodegenerative Diseases
Therapeutics

Keywords

  • Amyloid
  • autophagy
  • cognition
  • dementia
  • heat-shock
  • neurodegeneration
  • protein aggregation
  • protein degradation
  • stress
  • transcription factor

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Late-onset Alzheimer's disease, heating up and foxed by several proteins : Pathomolecular effects of the aging process. / Perez, Felipe P.; Bose, David; Maloney, Bryan; Nho, Kwangsik; Shah, Kavita; Lahiri, Debomoy.

In: Journal of Alzheimer's Disease, Vol. 40, No. 1, 2014, p. 1-17.

Research output: Contribution to journalArticle

@article{23bd648d3d8e4e5b912232d9c8423335,
title = "Late-onset Alzheimer's disease, heating up and foxed by several proteins: Pathomolecular effects of the aging process",
abstract = "Late-onset Alzheimer's disease (LOAD) is the most common neurodegenerative disorder in older adults, affecting over 50{\%} of those over age 85. Aging is the most important risk factor for the development of LOAD. Aging is associated with the decrease in the ability of cells to cope with cellular stress, especially protein aggregation. Here we describe how the process of aging affects pathways that control the processing and degradation of abnormal proteins including amyloid-β (Aβ). Genetic association studies in LOAD have successfully identified a large number of genetic variants involved in the development of the disease. However, there is a gap in understanding the interconnections between these pathomolecular events that prevent us from discovering therapeutic targets. We propose novel, pertinent links to elucidate how the biology of aging affects the sequence of events in the development of LOAD. Furthermore we analyze and synthesize the molecular-pathologic-clinical correlations of the aging process, involving the HSF1 and FOXO family pathways, Aβ metabolic pathway, and the different clinical stages of LOAD. Our new model postulates that the aging process would precede Aβ accumulation, and attenuation of HSF1 is an 'upstream' event in the cascade that results in excess Aβ and synaptic dysfunction, which may lead to cognitive impairment and/or trigger 'downstream' neurodegeneration and synaptic loss. Specific host factors, such as the activity of FOXO family pathways, would mediate the response to Aβ toxicity and the pace of progression toward the clinical manifestations of AD.",
keywords = "Amyloid, autophagy, cognition, dementia, heat-shock, neurodegeneration, protein aggregation, protein degradation, stress, transcription factor",
author = "Perez, {Felipe P.} and David Bose and Bryan Maloney and Kwangsik Nho and Kavita Shah and Debomoy Lahiri",
year = "2014",
doi = "10.3233/JAD-131544",
language = "English",
volume = "40",
pages = "1--17",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Late-onset Alzheimer's disease, heating up and foxed by several proteins

T2 - Pathomolecular effects of the aging process

AU - Perez, Felipe P.

AU - Bose, David

AU - Maloney, Bryan

AU - Nho, Kwangsik

AU - Shah, Kavita

AU - Lahiri, Debomoy

PY - 2014

Y1 - 2014

N2 - Late-onset Alzheimer's disease (LOAD) is the most common neurodegenerative disorder in older adults, affecting over 50% of those over age 85. Aging is the most important risk factor for the development of LOAD. Aging is associated with the decrease in the ability of cells to cope with cellular stress, especially protein aggregation. Here we describe how the process of aging affects pathways that control the processing and degradation of abnormal proteins including amyloid-β (Aβ). Genetic association studies in LOAD have successfully identified a large number of genetic variants involved in the development of the disease. However, there is a gap in understanding the interconnections between these pathomolecular events that prevent us from discovering therapeutic targets. We propose novel, pertinent links to elucidate how the biology of aging affects the sequence of events in the development of LOAD. Furthermore we analyze and synthesize the molecular-pathologic-clinical correlations of the aging process, involving the HSF1 and FOXO family pathways, Aβ metabolic pathway, and the different clinical stages of LOAD. Our new model postulates that the aging process would precede Aβ accumulation, and attenuation of HSF1 is an 'upstream' event in the cascade that results in excess Aβ and synaptic dysfunction, which may lead to cognitive impairment and/or trigger 'downstream' neurodegeneration and synaptic loss. Specific host factors, such as the activity of FOXO family pathways, would mediate the response to Aβ toxicity and the pace of progression toward the clinical manifestations of AD.

AB - Late-onset Alzheimer's disease (LOAD) is the most common neurodegenerative disorder in older adults, affecting over 50% of those over age 85. Aging is the most important risk factor for the development of LOAD. Aging is associated with the decrease in the ability of cells to cope with cellular stress, especially protein aggregation. Here we describe how the process of aging affects pathways that control the processing and degradation of abnormal proteins including amyloid-β (Aβ). Genetic association studies in LOAD have successfully identified a large number of genetic variants involved in the development of the disease. However, there is a gap in understanding the interconnections between these pathomolecular events that prevent us from discovering therapeutic targets. We propose novel, pertinent links to elucidate how the biology of aging affects the sequence of events in the development of LOAD. Furthermore we analyze and synthesize the molecular-pathologic-clinical correlations of the aging process, involving the HSF1 and FOXO family pathways, Aβ metabolic pathway, and the different clinical stages of LOAD. Our new model postulates that the aging process would precede Aβ accumulation, and attenuation of HSF1 is an 'upstream' event in the cascade that results in excess Aβ and synaptic dysfunction, which may lead to cognitive impairment and/or trigger 'downstream' neurodegeneration and synaptic loss. Specific host factors, such as the activity of FOXO family pathways, would mediate the response to Aβ toxicity and the pace of progression toward the clinical manifestations of AD.

KW - Amyloid

KW - autophagy

KW - cognition

KW - dementia

KW - heat-shock

KW - neurodegeneration

KW - protein aggregation

KW - protein degradation

KW - stress

KW - transcription factor

UR - http://www.scopus.com/inward/record.url?scp=84901758065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901758065&partnerID=8YFLogxK

U2 - 10.3233/JAD-131544

DO - 10.3233/JAD-131544

M3 - Article

C2 - 24326519

AN - SCOPUS:84901758065

VL - 40

SP - 1

EP - 17

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -